应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
IRON Disc Medicine
美国阵亡战士纪念日休市 05-22 16:00:00 EDT
66.82
-0.31
-0.46%
盘后
66.82
+0.00
0.00%
16:10 EDT
最高
69.31
最低
66.65
成交量
34.25万
今开
67.18
昨收
67.13
日振幅
3.96%
总市值
25.50亿
流通市值
21.97亿
总股本
3,816万
成交额
2,296万
换手率
1.04%
流通股本
3,289万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Disc Medicine公布DISC-0974治疗骨髓纤维化伴贫血患者的RALLY-MF二期试验数据将在美国临床肿瘤学会年会进行口头报告
美股速递 · 04-21
Disc Medicine公布DISC-0974治疗骨髓纤维化伴贫血患者的RALLY-MF二期试验数据将在美国临床肿瘤学会年会进行口头报告
Disc Medicine宣布完成Bitopertin治疗红细胞生成性原卟啉症的三期Apollo试验患者招募
美股速递 · 03-27
Disc Medicine宣布完成Bitopertin治疗红细胞生成性原卟啉症的三期Apollo试验患者招募
Disc Medicine高管表示：若后期试验成功，公司将选择传统审批路径而非加速通道
美股速递 · 02-17
Disc Medicine高管表示：若后期试验成功，公司将选择传统审批路径而非加速通道
Disc Medicine公司：FDA确认Aurora与Beacon试验提供充分证据，证明Bitopertin显著降低Ppix水平
美股速递 · 02-14
Disc Medicine公司：FDA确认Aurora与Beacon试验提供充分证据，证明Bitopertin显著降低Ppix水平
Disc Medicine, Inc.盘中异动 早盘大幅跳水5.02%报71.00美元
市场透视 · 02-12
Disc Medicine, Inc.盘中异动 早盘大幅跳水5.02%报71.00美元
独家：FDA推迟赛诺菲糖尿病药物Tzield与Disc Medicine血液疾病药物审评时间表 - 文件披露
美股速递 · 01-15
独家：FDA推迟赛诺菲糖尿病药物Tzield与Disc Medicine血液疾病药物审评时间表 - 文件披露
Disc Medicine称与FDA就比托普汀的沟通仍具建设性——市场快讯
投资观察 · 01-14
Disc Medicine称与FDA就比托普汀的沟通仍具建设性——市场快讯
Disc Medicine, Inc.盘中异动 早盘股价大跌5.34%报85.61美元
市场透视 · 2025-12-19
Disc Medicine, Inc.盘中异动 早盘股价大跌5.34%报85.61美元
小鹏IRON机器人将于5年内进入家庭
车质网 · 2025-11-19
小鹏IRON机器人将于5年内进入家庭
Disc Medicine, Inc.盘中异动 下午盘股价大跌5.05%
市场透视 · 2025-03-11
Disc Medicine, Inc.盘中异动 下午盘股价大跌5.05%
Disc Medicine, Inc.2024财年实现净利润-1.09亿美元，同比减少42.61%
市场透视 · 2025-03-08
Disc Medicine, Inc.2024财年实现净利润-1.09亿美元，同比减少42.61%
Scotiabank：维持Disc Medicine(IRON.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由73.00美元调整至75.00美元。
金融界 · 2025-03-03
Scotiabank：维持Disc Medicine(IRON.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由73.00美元调整至75.00美元。
Disc Medicine 2024财年GAAP每股收益$(3.96) 好于预期$(4.38)
财报速递 · 2025-02-27
Disc Medicine 2024财年GAAP每股收益$(3.96) 好于预期$(4.38)
Stifel：维持Disc Medicine(IRON.US)评级，由买入调整至买入评级, 目标价由90.00美元调整至94.00美元。
金融界 · 2025-01-24
Stifel：维持Disc Medicine(IRON.US)评级，由买入调整至买入评级, 目标价由90.00美元调整至94.00美元。
Disc Medicine, Inc.盘中异动 早盘快速下跌5.13%报55.50美元
市场透视 · 2025-01-23
Disc Medicine, Inc.盘中异动 早盘快速下跌5.13%报55.50美元
Disc Medicine, Inc.盘中异动 早盘股价大跌5.17%报57.39美元
市场透视 · 2025-01-22
Disc Medicine, Inc.盘中异动 早盘股价大跌5.17%报57.39美元
Scotiabank：维持Disc Medicine(IRON.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由70.00美元调整至73.00美元。
金融界 · 2025-01-22
Scotiabank：维持Disc Medicine(IRON.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由70.00美元调整至73.00美元。
Disc Medicine, Inc.盘中异动 股价大涨5.00%
市场透视 · 2025-01-22
Disc Medicine, Inc.盘中异动 股价大涨5.00%
加载更多
公司概况
公司名称：
Disc Medicine
所属市场：
NASDAQ
上市日期：
--
主营业务：
Disc Medicine,Inc.于2020年6月25日作为特拉华州公司注册成立。该公司是一家临床阶段的生物制药公司，专注于为严重血液疾病开发新型疗法。其研发管线针对红细胞生成和功能中的基本生物学通路，主要候选药物bitopertin正被开发用于治疗红细胞生成性卟啉症，其他候选药物则针对贫血及相关疾病。
发行价格：
--
{"stockData":{"symbol":"IRON","market":"US","secType":"STK","nameCN":"Disc Medicine","latestPrice":66.82,"timestamp":1779480000000,"preClose":67.13,"halted":0,"volume":342496,"hourTrading":{"tag":"盘后","latestPrice":66.82,"preClose":66.82,"latestTime":"16:10 EDT","volume":125846,"amount":8409029.72,"timestamp":1779480605029,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.004617905556383172,"floatShares":32885100,"shares":38160065,"eps":-6.60621,"marketStatus":"美国阵亡战士纪念日休市","change":-0.31,"latestTime":"05-22 16:00:00 EDT","open":67.18,"high":69.31,"low":66.65,"amount":22963506,"amplitude":0.039625,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.60621,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1779782400000},"marketStatusCode":7,"adr":0,"listingDate":1597204800000,"exchange":"NASDAQ","adjPreClose":67.13,"postHourTrading":{"tag":"盘后","latestPrice":66.82,"preClose":66.82,"latestTime":"16:10 EDT","volume":125846,"amount":8409029.72,"timestamp":1779480605029,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5957312098342128,"impliedVol":0.3654,"impliedVolPercentile":0.0159},"requestUrl":"/m/hq/s/IRON","defaultTab":"news","newsList":[{"id":"1131183162","title":"Disc Medicine公布DISC-0974治疗骨髓纤维化伴贫血患者的RALLY-MF二期试验数据将在美国临床肿瘤学会年会进行口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1131183162","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131183162?lang=zh_cn&edition=full","pubTime":"2026-04-21 22:02","pubTimestamp":1776780173,"startTime":"0","endTime":"0","summary":"Disc Medicine公司宣布，其针对骨髓纤维化伴贫血患者开展的DISC-0974药物RALLY-MF二期临床试验数据，已被遴选在美国临床肿瘤学会年度会议上进行口头报告。这一重要研究成果的展示，标志着该创新疗法在血液疾病治疗领域取得的突破性进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","IRON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185147425","title":"Disc Medicine宣布完成Bitopertin治疗红细胞生成性原卟啉症的三期Apollo试验患者招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1185147425","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185147425?lang=zh_cn&edition=full","pubTime":"2026-03-27 04:31","pubTimestamp":1774557073,"startTime":"0","endTime":"0","summary":"Disc Medicine已顺利完成针对红细胞生成性原卟啉症（EPP）的研究药物Bitopertin的三期临床试验——Apollo试验的患者招募工作。这一关键里程碑标志着该药物临床开发进入新阶段，为后续数据收集和分析奠定基础。\n红细胞生成性原卟啉症是一种罕见的光敏感性皮肤病，Bitopertin作为一种创新疗法，其三期临床试验的推进备受行业关注。此次顺利完成患者招募，展现了Disc Medicine在罕见病治疗领域的执行效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","IRON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120019991","title":"Disc Medicine高管表示：若后期试验成功，公司将选择传统审批路径而非加速通道","url":"https://stock-news.laohu8.com/highlight/detail?id=1120019991","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120019991?lang=zh_cn&edition=full","pubTime":"2026-02-17 21:17","pubTimestamp":1771334232,"startTime":"0","endTime":"0","summary":"Disc Medicine高管在电话会议中透露，如果公司当前进行的后期临床试验取得积极成果，将优先考虑通过传统审批途径向监管机构提交上市申请，而非选择加速审批通道。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRON","BK4139","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105734608","title":"Disc Medicine公司：FDA确认Aurora与Beacon试验提供充分证据，证明Bitopertin显著降低Ppix水平","url":"https://stock-news.laohu8.com/highlight/detail?id=1105734608","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105734608?lang=zh_cn&edition=full","pubTime":"2026-02-14 04:06","pubTimestamp":1771013171,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已正式认可，由Disc Medicine公司开展的Aurora及Beacon临床试验所提交的数据充分证明，其在研药物Bitopertin能够显著降低患者血液中的原卟啉（Ppix）水平。这一关键进展为Bitopertin的后续开发及潜在获批奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0053671581.USD","IRON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611973938","title":"Disc Medicine, Inc.盘中异动 早盘大幅跳水5.02%报71.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611973938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611973938?lang=zh_cn&edition=full","pubTime":"2026-02-12 00:22","pubTimestamp":1770826946,"startTime":"0","endTime":"0","summary":"北京时间2026年02月12日00时22分，Disc Medicine, Inc.股票出现异动，股价大幅下跌5.02%。Disc Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。其相关个股中，Quince Therapeutics, Inc.、Ernexa Therapeutics Inc C/Wts 04/02/2030、内克塔治疗涨幅较大，Pmgc Holdings Inc.、Quince Therapeutics, Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为2237.49%、608.53%、188.02%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Quince Therapeutics, Inc.、Ernexa Therapeutics Inc C/Wts 04/02/2030，振幅分别为49.15%、46.56%、45.00%。Disc Medicine, Inc.公司简介：Disc Medicine Inc 是一家临床阶段的生物制药公司，专注血液病新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021200222797a5d60f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021200222797a5d60f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IRON","LU0053671581.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104011542","title":"独家：FDA推迟赛诺菲糖尿病药物Tzield与Disc Medicine血液疾病药物审评时间表 - 文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1104011542","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104011542?lang=zh_cn&edition=full","pubTime":"2026-01-15 19:01","pubTimestamp":1768474878,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局已决定推迟对赛诺菲安万特旗下糖尿病治疗药物Tzield以及Disc Medicine公司血液疾病治疗药物的审评时间表。业内观察人士指出，FDA的审评延期通常涉及对补充数据或生产信息的进一步核查，这属于新药审评流程中的常规环节。对于赛诺菲安万特而言，Tzield作为其糖尿病管线的重要候选药物，审评进度的变化将直接影响该产品的上市时间表。而Disc Medicine的血液疾病药物同样面临关键审评节点，此次延期将对公司的研发里程碑产生连锁影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2168564065.EUR","BK4588","LU1868837136.USD","IE00BKDWB100.SGD","LU1934455277.USD","IE00BBT3K403.USD","IE00B4JS1V06.HKD","SG9999017495.SGD","LU1868837300.USD","LU2468319806.SGD","BK4139","LU0289739699.SGD","LU1699723380.USD","LU1868836591.USD","IE00BWXC8680.SGD","LU1023059063.AUD","LU2456880835.USD","LU0640476718.USD","LU1057294990.SGD","LU1064131342.USD","SG9999001176.USD","IE00BFSS8Q28.SGD","SG9999001176.SGD","BK4007","LU1037948541.HKD","LU2552382058.USD","SGXZ57979304.SGD","IE00BLSP4239.USD","LU0106261372.USD","LU1814569148.SGD","LU1066051811.HKD","LU0882574055.USD","LU2361045086.USD","LU1037948897.HKD","LU1232071149.USD","LU1868836757.USD","LU1035773651.USD","LU2237443465.HKD","LU0079474960.USD","LU1035775433.USD","LU2265009873.SGD","LU0353189763.USD","LU1989772923.USD","SG9999018865.SGD","IE00BFTCPJ56.SGD","BK4581","LU0320765646.SGD","LU1623119135.USD","LU0265550359.USD","LU2746668461.USD","LU1093756325.SGD","IE0005OL40V9.USD","LU1291159041.SGD","LU1571399168.USD","LU2089984988.USD","LU2357305700.SGD","LU2125154935.USD","LU1983299246.USD","SG9999014914.USD","LU0823434583.USD","LU0417517546.SGD","LU2552382215.SGD","LU2602419157.SGD","IE00BLSP4452.SGD","LU0980610538.SGD","LU1804176565.USD","SG9999001440.SGD","IRON","LU1201861249.SGD","LU1929549753.HKD","LU1116320737.USD","SG9999014880.SGD","SGXZ99366536.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU1061106388.HKD","BK4533","LU1366192091.USD","LU1989771016.USD","LU0965509283.SGD","LU1280957306.USD","LU1934455194.USD","LU0354030438.USD","LU0320765059.SGD","IE00B2B36J28.USD","LU1127390331.HKD","LU0070302665.USD","LU1551013342.USD","LU1917777945.USD","LU0265550946.USD","SG9999002224.SGD","BK4559","LU0648001328.SGD","LU1066051498.USD","BK4550","LU0198837287.USD","LU0385154629.USD","LU0985320562.USD","SNY","LU0114720955.EUR","LU2361044865.SGD","LU2237443549.SGD","LU2360106947.USD","LU2552382132.HKD","IE00BJJMRZ35.SGD","LU0211331839.USD","LU0238689110.USD","SGXZ81514606.USD","IE00BKPKM429.USD","LU0203347892.USD","SG9999002232.USD","SG9999015986.USD","LU1116320901.HKD","LU0689472784.USD","LU2112291526.USD","SG9999014559.SGD","LU0471298694.HKD","SG9999015945.SGD","LU1430594728.SGD","LU2106854487.HKD","LU1267930730.SGD","LU2462157665.USD","SGXZ51526630.SGD","LU0058720904.USD","LU1720051108.HKD","BK4516","LU1548497426.USD","IE0004445015.USD","LU0882574139.USD","SG9999014542.SGD","SG9999015341.SGD","LU1720051017.SGD","LU0823434740.USD","LU0316494557.USD","LU1988902786.USD","LU0965509101.SGD","LU0820561818.USD","LU2237443622.USD","IE00B1XK9C88.USD","LU0943347566.SGD","LU1551013425.SGD","LU0130517989.USD","LU1069347547.HKD","LU2168564495.EUR","IE00B775H168.HKD","LU2471134796.USD","LU0787776722.HKD","LU2125154778.USD","SG9999013999.USD","LU2750360997.AUD","LU2023250843.SGD","LU2360032135.SGD","SGXZ31699556.SGD","BK4534","LU0672654240.SGD","LU0203202063.USD","IE00BK4W5M84.HKD","LU0471298777.SGD","LU0456855351.SGD","LU0432979614.USD","LU1941712264.USD","LU1585245621.USD","LU2264538146.SGD","IE00BN29S564.USD","LU2063271972.USD","LU0096364046.USD","LU2168563687.JPY","LU2168564222.USD","LU0109391861.USD","LU0708995401.HKD","LU2461242641.AUD","LU0353189680.USD","LU2471134879.HKD","LU2491049909.HKD","IE000M9KFDE8.USD","LU0266013472.USD","LU0203201768.USD","IE00BK4W5L77.USD","LU0256863902.USD","LU1974910355.USD","LU2746668974.SGD","IE00BN8TJ469.HKD","LU0061475181.USD","LU0320765489.SGD","LU2211815571.USD","LU2087625088.SGD","LU0861579265.USD","LU2237443895.HKD","LU0203345920.USD","LU0820561909.HKD","LU0094547139.USD","LU1093756168.USD","LU1066051225.USD","LU1162221912.USD","LU0466842654.USD","LU2471134523.USD","LU0683600562.USD","BK4599","LU0965509010.AUD","LU0889565916.HKD","LU2491050071.SGD","LU0053671581.USD","LU0256863811.USD","LU1941712348.USD","LU2471134952.CNY","LU2361044949.HKD","IE00B1BXHZ80.USD","LU0965508806.USD","LU0208291251.USD","SG9999015952.SGD","LU2108987350.USD","LU2168564149.EUR","IE00BJJMRY28.SGD","BK4585","LU0823416689.USD","LU2023250504.SGD","GB00BDT5M118.USD","LU1712237335.SGD","IE0009355771.USD","LU0786609619.USD","LU2237438978.USD","LU2417539215.USD","LU2750360641.GBP","LU0109394709.USD","LU0323591593.USD","LU2236285917.USD","LU0130102774.USD","IE00BJJMRX11.SGD","LU0225283273.USD","LU1868836914.USD","LU0354030511.USD","SG9999014567.USD","LU1069344957.HKD","LU0097036916.USD","LU0477156953.USD","IE00B7KXQ091.USD","SG9999014575.USD","SG9999015358.SGD","SG9999018857.SGD","LU2324357040.USD","LU1066053197.SGD","LU0098860793.USD","LU0122379950.USD","IE0002141913.USD","LU2237443382.USD","SG9999015978.USD","LU0234572021.USD","IE00BSNM7G36.USD","LU2491050154.USD","IE00BJT1NW94.SGD","LU1323610961.USD","LU0006306889.USD","LU2237443978.SGD","SG9999014898.SGD","IE00BFSS7M15.SGD","IE00BJLML261.HKD","LU1934455863.HKD","LU1989772840.SGD","SG9999014906.USD","IE0004445239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164925448","title":"Disc Medicine称与FDA就比托普汀的沟通仍具建设性——市场快讯","url":"https://stock-news.laohu8.com/highlight/detail?id=1164925448","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164925448?lang=zh_cn&edition=full","pubTime":"2026-01-14 03:18","pubTimestamp":1768331911,"startTime":"0","endTime":"0","summary":"Disc Medicine管理层在摩根大通医疗健康大会上的一场分析师活动中重申，其与美国食品药品监督管理局就比托普汀获批事宜的沟通依然富有成效。据BMO发布的一份报告指出，该公司正试图消除投资者因STAT News的一篇报道而产生的担忧，该报道称生物制品评价与研究中心主任Vinay Prasad对比托普汀的申请持怀疑态度。分析师还补充道，BMO对Disc Medicine就该药物所做的商业化准备工作印象深刻。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","IRON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592114160","title":"Disc Medicine, Inc.盘中异动 早盘股价大跌5.34%报85.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592114160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592114160?lang=zh_cn&edition=full","pubTime":"2025-12-19 23:04","pubTimestamp":1766156641,"startTime":"0","endTime":"0","summary":"北京时间2025年12月19日23时04分，Disc Medicine, Inc.股票出现波动，股价快速下跌5.34%。截至发稿，该股报85.61美元/股，成交量31.0951万股，换手率0.82%，振幅6.34%。Disc Medicine, Inc.股票所在的生物技术行业中，整体涨幅为1.10%。Disc Medicine, Inc.公司简介：Disc Medicine Inc 是一家临床阶段的生物制药公司，专注血液病新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121923040297a07fb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121923040297a07fb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0053671581.USD","IRON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584998146","title":"小鹏IRON机器人将于5年内进入家庭","url":"https://stock-news.laohu8.com/highlight/detail?id=2584998146","media":"车质网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584998146?lang=zh_cn&edition=full","pubTime":"2025-11-19 09:05","pubTimestamp":1763514300,"startTime":"0","endTime":"0","summary":"在小鹏Q3业绩会后续QA环节中，大师兄XP-何小鹏 称：什么时候机器人可以进入家庭？另外，他还称：IRON将于2030年销量达100万台。IRON的量产有特别多的挑战，我们期望IRON最后可以是一个能用语言沟通并且让它做事情的机器人，我们希望它是一个可以通过简单教导、培训就可以干活的机器人。小鹏汽车希望最开始机器人能够在商业场景，包括导购、导览、前台以及导寻的商业化场景落地。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119090645950d45a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119090645950d45a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4551","BK4505","09868","BK4555","BK4526","LU0053671581.USD","XPEV","IRON","EVS.SI","BK4099"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2518885827","title":"Disc Medicine, Inc.盘中异动 下午盘股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518885827","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518885827?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:04","pubTimestamp":1741633466,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时04分，Disc Medicine, Inc.股票出现波动，股价快速跳水5.05%。Disc Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Disc Medicine, Inc.公司简介：Disc Medicine Inc 是一家临床阶段的生物制药公司，致力于改变血液疾病患者的生活。Disc Medicine 致力于开发治疗方法，为许多患有血液疾病的患者提供帮助并带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103042698a2dcb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103042698a2dcb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IRON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517437406","title":"Disc Medicine, Inc.2024财年实现净利润-1.09亿美元，同比减少42.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517437406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517437406?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363244,"startTime":"0","endTime":"0","summary":"3月8日，Disc Medicine, Inc.公布财报，公告显示公司2024财年净利润为-1.09亿美元，同比减少42.61%；其中营业收入为0.00美元，每股基本收益为-3.96美元。机构评级：截至2025年3月8日，当前有11家机构对Disc Medicine, Inc.目标价做出预测，其中目标均价为94.82美元，其中最低目标价为75.00美元，最高目标价为118.00美元。Disc Medicine 致力于开发治疗方法，为许多患有血液疾病的患者提供帮助并带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000140a2647ec4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000140a2647ec4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IRON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516637498","title":"Scotiabank：维持Disc Medicine(IRON.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由73.00美元调整至75.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637498","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516637498?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:11","pubTimestamp":1741014689,"startTime":"0","endTime":"0","summary":"Scotiabank：维持Disc Medicine(IRON.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由73.00美元调整至75.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/03231148494582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IRON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169043775","title":"Disc Medicine 2024财年GAAP每股收益$(3.96) 好于预期$(4.38)","url":"https://stock-news.laohu8.com/highlight/detail?id=1169043775","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169043775?lang=zh_cn&edition=full","pubTime":"2025-02-27 21:14","pubTimestamp":1740662063,"startTime":"0","endTime":"0","summary":"$Disc Medicine(IRON)$ 2024财年GAAP每股收益$(3.96) 好于预期$(4.38)以上内容来自Benzinga Earnings专栏，原文如下：$Disc Medicine(IRON)$ FY 2024 GAAP EPS $(3.96) Beats $(4.38) Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Disc Medicine 2024财年GAAP每股收益$(3.96) 好于预期$(4.38)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505939862","title":"Stifel：维持Disc Medicine(IRON.US)评级，由买入调整至买入评级, 目标价由90.00美元调整至94.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2505939862","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505939862?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:41","pubTimestamp":1737733306,"startTime":"0","endTime":"0","summary":"Stifel：维持Disc Medicine(IRON.US)评级，由买入调整至买入评级, 目标价由90.00美元调整至94.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/24234147811624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IRON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505755011","title":"Disc Medicine, Inc.盘中异动 早盘快速下跌5.13%报55.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505755011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505755011?lang=zh_cn&edition=full","pubTime":"2025-01-23 22:31","pubTimestamp":1737642672,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日22时31分，Disc Medicine, Inc.股票出现波动，股价大幅跳水5.13%。截至发稿，该股报55.50美元/股，成交量19.8336万股，换手率0.67%，振幅0.21%。Disc Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Disc Medicine, Inc.公司简介：Disc Medicine Inc 是一家临床阶段的生物制药公司，致力于改变血液疾病患者的生活。Disc Medicine 致力于开发治疗方法，为许多患有血液疾病的患者提供帮助并带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223113abb5fa4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223113abb5fa4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IRON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505372642","title":"Disc Medicine, Inc.盘中异动 早盘股价大跌5.17%报57.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505372642","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505372642?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:32","pubTimestamp":1737556320,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时32分，Disc Medicine, Inc.股票出现波动，股价快速下挫5.17%。截至发稿，该股报57.39美元/股，成交量1.105万股，换手率0.04%，振幅0.31%。Disc Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Disc Medicine, Inc.公司简介：Disc Medicine Inc 是一家临床阶段的生物制药公司，致力于改变血液疾病患者的生活。Disc Medicine 致力于开发治疗方法，为许多患有血液疾病的患者提供帮助并带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223201abb4a5ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223201abb4a5ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IRON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505723423","title":"Scotiabank：维持Disc Medicine(IRON.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由70.00美元调整至73.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2505723423","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505723423?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:06","pubTimestamp":1737554761,"startTime":"0","endTime":"0","summary":"Scotiabank：维持Disc Medicine(IRON.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由70.00美元调整至73.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/22220647722286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IRON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505019772","title":"Disc Medicine, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505019772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505019772?lang=zh_cn&edition=full","pubTime":"2025-01-22 01:11","pubTimestamp":1737479461,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日01时11分，Disc Medicine, Inc.股票出现异动，股价急速上涨5.00%。Disc Medicine, Inc.股票所在的生物技术行业中，整体涨幅为1.87%。Disc Medicine, Inc.公司简介：Disc Medicine Inc 是一家临床阶段的生物制药公司，致力于改变血液疾病患者的生活。Disc Medicine 致力于开发治疗方法，为许多患有血液疾病的患者提供帮助并带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122011101960bd54f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122011101960bd54f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IRON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.discmedicine.com","stockEarnings":[{"period":"1week","weight":-0.0006},{"period":"1month","weight":-0.0415},{"period":"3month","weight":0.089},{"period":"6month","weight":-0.2784},{"period":"1year","weight":0.3909},{"period":"ytd","weight":-0.1585}],"compareEarnings":[{"period":"1week","weight":0.0088},{"period":"1month","weight":0.0484},{"period":"3month","weight":0.0815},{"period":"6month","weight":0.1314},{"period":"1year","weight":0.2788},{"period":"ytd","weight":0.0934}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Disc Medicine,Inc.于2020年6月25日作为特拉华州公司注册成立。该公司是一家临床阶段的生物制药公司，专注于为严重血液疾病开发新型疗法。其研发管线针对红细胞生成和功能中的基本生物学通路，主要候选药物bitopertin正被开发用于治疗红细胞生成性卟啉症，其他候选药物则针对贫血及相关疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.025919},{"month":2,"riseRate":0.666667,"avgChangeRate":0.005202},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.08148},{"month":4,"riseRate":0.5,"avgChangeRate":-0.005363},{"month":5,"riseRate":0.666667,"avgChangeRate":0.035252},{"month":6,"riseRate":0.8,"avgChangeRate":0.10084},{"month":7,"riseRate":0.4,"avgChangeRate":-0.052496},{"month":8,"riseRate":0.8,"avgChangeRate":0.093002},{"month":9,"riseRate":0.5,"avgChangeRate":-0.006486},{"month":10,"riseRate":0.333333,"avgChangeRate":0.020523},{"month":11,"riseRate":0.666667,"avgChangeRate":0.064648},{"month":12,"riseRate":0.666667,"avgChangeRate":0.034}],"exchange":"NASDAQ","name":"Disc Medicine","nameEN":"Disc Medicine"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Disc Medicine(IRON)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Disc Medicine(IRON)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Disc Medicine,IRON,Disc Medicine股票,Disc Medicine股票老虎,Disc Medicine股票老虎国际,Disc Medicine行情,Disc Medicine股票行情,Disc Medicine股价,Disc Medicine股市,Disc Medicine股票价格,Disc Medicine股票交易,Disc Medicine股票购买,Disc Medicine股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Disc Medicine(IRON)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Disc Medicine(IRON)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}